A multi center open label non controlled Phase II study to evaluate efficacy and sfety of oral Nilotinib in pediatric patients wit newly diagnosed Ph chronic myelogenous leukemia CML in chronic phase CP or with Ph CML in CP or accelerated phase AP resistant or intolerant to either imatinib or dasatinib | AVESİS

İstanbul Üniversitesi Akademik Veri Yönetim Sistemi

A multi center open label non controlled Phase II study to evaluate efficacy and sfety of oral Nilotinib in pediatric patients wit newly diagnosed Ph chronic myelogenous leukemia CML in chronic phase CP or with Ph CML in CP or accelerated phase AP resistant or intolerant to either imatinib or dasatinib

Karakaş Z. (Yürütücü), Karaman S.

Diğer Uluslararası Fon Programları, 2014 - 2020

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Eylül 2014
Bitiş Tarihi: Kasım 2020

Proje Özeti

A multi center open label non controlled Phase II study to evaluate efficacy and sfety of oral Nilotinib in pediatric patients wit newly diagnosed Ph chronic myelogenous leukemia CML in chronic phase CP or with Ph CML in CP or accelerated phase AP resistant or intolerant to either imatinib or dasatinib